Policy Archives | Page 11 of 15

More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.

by Sue Rochman

Patient Advocates Go to Washington

Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.

by Marci A. Landsmann

The Affordable Care Act and Cancer Patients

Cancer survivors tell their stories and researchers take a broad view.

by Kevin McLaughlin

Forward Look

Inside the 21st Century Cures Act

Legislation brings high hopes for cancer research.

by Stephen Ornes

Screening Gets Personal

Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?

by Kate Yandell

Forward Look

The Impact of Rising Drug Costs

Higher prices of oral medicines may affect financial well-being.

by Chris Palmer

From the Editor-in-Chief

Can Big Data Launch Cancer Research?

Analysis of big data in cancer medicine will be key to delivering on the cancer moonshot.

by William G. Nelson, MD, PhD

Forward Look

Vice President Joe Biden Brings “Moonshot” to AACR Annual Meeting

Vice President Joe Biden is leading a new, national $1 billion Moonshot initiative to propel cancer research. Speaking in April at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans, Biden emphasized the need for scientists to collaborate to move cancer research forward. “There is more brainpower in this room than exists […]

by Sue Rochman